tiprankstipranks
Summit Therapeutics PLC (SMMT)
NASDAQ:SMMT
US Market
SMMT
Summit Therapeutics
RESEARCH TOOLSreports
Want to see SMMT full AI Analyst Report?

Summit Therapeutics (SMMT) Financial Statements

1,902 Followers

Summit Therapeutics Financial Overview

Summit Therapeutics's market cap is currently $12.90B. The company's EPS TTM is $-1.4; its P/E ratio is -19.40; Summit Therapeutics is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 583.19K$ 1.34M
Gross Profit$ 0.00$ 0.00$ 0.00$ 583.19K$ 1.34M
Operating Income$ -1.09B$ -180.51M$ -478.23M$ -59.63M$ -63.73M
EBITDA$ -1.08B$ -168.46M$ -69.45M$ -51.58M$ -62.74M
Net Income$ -1.08B$ -176.77M$ -482.37M$ -65.17M$ -65.52M
Balance Sheet
Cash & Short-Term Investments$ 529.49M$ 329.50M$ 147.38M$ 284.18M$ 53.22M
Total Assets$ 557.50M$ 348.05M$ 160.60M$ 541.43M$ 84.04M
Total Debt$ 15.50M$ 5.77M$ 83.96M$ 422.89M$ 2.06M
Net Debt$ -151.68M$ -78.03M$ 27.44M$ 138.71M$ -51.15M
Total Liabilities$ 68.52M$ 37.41M$ 99.12M$ 438.18M$ 22.30M
Stockholders' Equity$ 488.98M$ 310.64M$ 61.48M$ 103.25M$ 61.74M
Cash Flow
Free Cash Flow$ -240.15M$ -113.67M$ -60.85M$ -34.41M$ -54.03M
Operating Cash Flow$ -239.67M$ -113.56M$ -60.74M$ -33.90M$ -53.81M
Investing Cash Flow$ -129.37M$ -164.09M$ -465.14M$ -508.68K$ -226.83K
Financing Cash Flow$ 458.31M$ 304.63M$ 68.46M$ 505.62M$ 57.76M
Currency in USD

Summit Therapeutics Earnings and Revenue History

Income Statement >

Summit Therapeutics Debt to Assets

Balance Sheet >

Summit Therapeutics Cash Flow

Cash Flow >

Summit Therapeutics Forecast EPS vs Actual EPS

Earnings >